Related Experiment Video

Updated: May 16, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Voriconazole in clinical practice

Małgorzata Mikulska1, Andrea Novelli, Franco Aversa

  • 1Division of Infectious Diseases, University of Genoa and San Martino University Hospital, Genoa, Italy. m.mikulska@unige.it

Journal of Chemotherapy (Florence, Italy)
|November 24, 2012
PubMed

Insights

Voriconazole is a crucial antifungal for immunocompromised patients but has variable effects due to metabolism and drug interactions. Therapeutic drug monitoring is vital for optimizing voriconazole efficacy and safety.

Area of Science:

  • Medical Mycology
  • Clinical Pharmacology

Background:

  • Invasive fungal diseases (IFDs) pose significant risks in immunocompromised individuals.
  • Voriconazole is a primary treatment for invasive aspergillosis and other serious fungal infections.
  • Voriconazole exhibits complex pharmacokinetics, including non-linear absorption and extensive hepatic metabolism via cytochrome P450 enzymes.

Purpose of the Study:

  • To provide a comprehensive overview of voriconazole's pharmacological properties.
  • To highlight the importance of understanding voriconazole metabolism, drug interactions, and population-specific dosing.
  • To emphasize the role of therapeutic drug monitoring in optimizing voriconazole treatment outcomes.

Main Methods:

  • Review of pharmacological, mycological, and clinical data related to voriconazole.
  • Analysis of factors influencing voriconazole pharmacokinetics, including age, genetics, and drug-drug interactions.
  • Evaluation of voriconazole's narrow therapeutic index and potential toxicities.

Main Results:

  • Voriconazole's efficacy is influenced by significant interpatient pharmacokinetic variability.
  • High serum levels, 3-5 times above the efficacy threshold, are associated with increased toxicity.
  • Optimal voriconazole use requires careful consideration of its pharmacological profile and patient-specific factors.

Conclusions:

  • Understanding voriconazole's complex pharmacology is essential for effective clinical management.
  • Therapeutic drug monitoring is a key strategy to enhance voriconazole efficacy and mitigate toxicity.
  • This review aims to optimize voriconazole utilization in clinical practice through a synthesis of key aspects.

More Related Videos

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...